Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals
- PMID: 2258623
Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals
Abstract
T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection. In HIV-1, the sequences that respond to these signaling events are found in the long terminal repeat (LTR) and comprise the transcriptional enhancer, which contains two conserved binding sites for the nuclear factor kappa B (NF kappa B). The corresponding region in the second AIDS retrovirus, HIV-2, contains a conserved and a divergent NF kappa B binding site. We demonstrate that the HIV-1 LTR responds better than the HIV-2 LTR to T cell activation signals. These qualitative differences in the response to T cell activation are reproduced not only when HIV-1 or HIV-2 enhancers are placed upstream of a heterologous promoter but also when these enhancers are switched between their respective LTR. In electrophoretic mobility shift assays, NF kappa B binds to both conserved sites in the HIV-1 transcriptional enhancer and only to the single conserved site in the HIV-2 transcriptional enhancer. Instead of NF kappa B, the activator protein 3 binds to the divergent site in HIV-2. In conclusion, HIV-1 and HIV-2 are differentially regulated by T cell activation signals, and this difference may account for the longer period of viral latency observed with HIV-2 than with HIV-1 infection.
Similar articles
-
Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.Virology. 1995 Apr 20;208(2):753-61. doi: 10.1006/viro.1995.1207. Virology. 1995. PMID: 7747447
-
Regulation of HIV-1 gene expression by NF-IL6.J Mol Biol. 1996 Sep 27;262(3):327-35. doi: 10.1006/jmbi.1996.0516. J Mol Biol. 1996. PMID: 8844998
-
Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.Virology. 2000 Sep 1;274(2):262-77. doi: 10.1006/viro.2000.0476. Virology. 2000. PMID: 10964770
-
Human immunodeficiency virus type-1 transcription: role of the 5'-untranslated leader region (review).Int J Mol Med. 1998 May;1(5):875-81. doi: 10.3892/ijmm.1.5.875. Int J Mol Med. 1998. PMID: 9852310 Review.
-
Modulation of HIV-enhancer activity by heterologous agents: a minireview.Gene. 1991 May 30;101(2):165-70. doi: 10.1016/0378-1119(91)90407-3. Gene. 1991. PMID: 2055485 Review.
Cited by
-
Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-Bissau.Clin Exp Immunol. 2005 Mar;139(3):483-9. doi: 10.1111/j.1365-2249.2005.02723.x. Clin Exp Immunol. 2005. PMID: 15730394 Free PMC article.
-
Differential activation of human immunodeficiency virus type 1 and 2 transcription by specific T-cell activation signals.J Virol. 1993 Aug;67(8):5035-40. doi: 10.1128/JVI.67.8.5035-5040.1993. J Virol. 1993. PMID: 8331739 Free PMC article.
-
Human immunodeficiency virus type 2 produces a defect in CD3-gamma gene transcripts similar to that observed for human immunodeficiency virus type 1.J Virol. 1999 Jun;73(6):5207-13. doi: 10.1128/JVI.73.6.5207-5213.1999. J Virol. 1999. PMID: 10233990 Free PMC article.
-
Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection.J Virus Erad. 2017 Jan 1;3(1):7-14. doi: 10.1016/S2055-6640(20)30300-9. J Virus Erad. 2017. PMID: 28275453 Free PMC article.
-
Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and kappa B regulatory elements.J Virol. 1992 Sep;66(9):5479-84. doi: 10.1128/JVI.66.9.5479-5484.1992. J Virol. 1992. PMID: 1501284 Free PMC article.